Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.06%
#3 CoW Protocol CoW Protocol +37.63%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +28.04%
#6 Walrus Walrus +22.05%
#7 Codatta Codatta +21.20%
#8 Enso Enso +19.64%
#9 The Black Bull The Black Bull +17.55%
#10 Tutorial Tutorial +14.31%
Coin of the day
EXOD EXOD
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Kedudukan dalam Saham #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Harga Saham
$0.117
Disegerakkan terakhir: 2025-04-04
Modal Pasaran
$2.45M
Perubahan (1 hari)
-13.59%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Carmell Therapeutics Corporation (CTCX)

Kategori

Healthcare
Bilangan saham terbitan bagi Carmell Therapeutics Corporation (CTCX)
Bilangan saham terbitan setakat June 2026: 2.48M
Menurut laporan kewangan terkini dan harga saham Carmell Therapeutics Corporation, bilangan saham terbitan semasa ialah 2.48M. Pada akhir December 2023, syarikat mempunyai 20.77M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Carmell Therapeutics Corporation (CTCX) dari 2021 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 2.48M -88.16%
2024 20.91M 0.64%
2023 20.77M 5.08%
2022 19.77M 0.00%
2021 19.77M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 10,157.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 2,412.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE